We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

146 hedge funds and large institutions have $336M invested in Alaunos Therapeutics in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 32

51% more call options, than puts

Call options by funds: $5.34M | Put options by funds: $3.54M

39% more capital invested

Capital invested by funds: $242M → $336M (+$94.2M)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

0.01% more ownership

Funds ownership: 0.31% → 0.32% (+0.01%)

0% more funds holding

Funds holding: 146 → 146 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
146
Holders Change
–
Holders Change %
0%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
58
Reduced
32
Closed
16
Calls
$5.34M
Puts
$3.54M
Net Calls
+$1.8M
Net Calls Change
+$816K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$4.94M
2
Goldman Sachs
Goldman Sachs
New York
+$4.7M
3
BlackRock
BlackRock
New York
+$4.15M
4
Millennium Management
Millennium Management
New York
+$3.86M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.54M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$9.19M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.86M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.28M
4
Morgan Stanley
Morgan Stanley
New York
-$1.24M
5
SMH
Sanders Morris Harris
Texas
-$930K
Name Holding Trade Value Shares
Change 		Change in
Stake
LWA
126
Lenox Wealth Advisors
New York
$16K – – –
S
127
SignatureFD
Georgia
$13K -$2.67K -6 -19%
Fidelity Investments
128
Fidelity Investments
Massachusetts
$10K +$8.92K +20 New
GWM
129
Geneos Wealth Management
Colorado
$8K -$446 -1 -6%
OSAM
130
O'Shaughnessy Asset Management
Connecticut
$8K +$7.58K +17 New
Nisa Investment Advisors
131
Nisa Investment Advisors
Missouri
$7K – – –
QT
132
Quantbot Technologies
New York
$7K +$6.69K +15 New
APA
133
American Portfolios Advisors
New York
$4.26K – – –
CWP
134
CFM Wealth Partners
Texas
$4K – – –
TWA
135
TCI Wealth Advisors
Arizona
$4K – – –
WEC
136
Winslow Evans & Crocker
Massachusetts
$3K – – –
JFA
137
JNBA Financial Advisors
Minnesota
$2K – – –
US Bancorp
138
US Bancorp
Minnesota
$2K – – –
MLFP
139
MPS Loria Financial Planners
Illinois
$2K +$1.34K +3 New
GT
140
Glenmede Trust
Pennsylvania
$2K +$2.67K +6 New
FWM
141
Focused Wealth Management
New York
$1K – – –
SFS
142
Sowell Financial Services
Arkansas
$1K – – –
WFMPM
143
Woodley Farra Manion Portfolio Management
Indiana
$1K – – –
RWB
144
RMR Wealth Builders
New Jersey
$1K +$1.34K +3 New
TI
145
tru Independence
Oregon
$701 -$197K -441 -24%
EC
146
EcoR1 Capital
California
– -$9.19M -25,000 Closed
VIA
147
Vident Investment Advisory
Georgia
– -$707K -1,925 Closed
SMH
148
Sanders Morris Harris
Texas
– -$930K -1,341 Closed
UC
149
Unio Capital
New Jersey
– -$368K -1,000 Closed
QIM
150
Quantitative Investment Management
Virginia
– -$215K -587 Closed
3 4 5
6
7

TCRT Hedge Fund Activity: Q2 2020 in Review

146 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2020, worth a combined $336M — up 39% from $242M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TCRT positions and 16 closed out — a net gain of 1 holder — while 58 added to existing stakes and 32 trimmed.

The largest buyer was State Street, adding an estimated $4.94M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $9.19M sold.

  • 146 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $336M of Alaunos Therapeutics stock for Q2 2020, up 39% quarter-over-quarter.
  • 17 funds opened new Alaunos Therapeutics positions in Q2 2020 and 16 closed out, a net change of +1 holder.
  • The largest Alaunos Therapeutics buyer in Q2 2020 was State Street, an estimated $4.94M added.
  • The largest Alaunos Therapeutics seller in Q2 2020 was EcoR1 Capital, an estimated $9.19M sold.

Based on aggregated 13F filings for Q2 2020.